background red circles image

Know Streck. Know Quality.

The 20-Day QC Study​ Isn’t a CLIA Requirement

Get your free copy! Fill out the form to download and receive our 10-page guide on molecular quality control verification.

The free Laboratory Quality Control Verification Strategic Guidance shows how control type, IQCP status and verification scope choices made early can affect how switching controls hold up through daily workflow and accreditation review.​

50+ years

of scientific excellence in diagnostics​

42 CFR 493.1256​

the primary CLIA regulation behind this guide​

1 + 4

one confirmatory run plus four monitoring runs in the phased model​


What’s inside the handbook

Six chapters built to take your assay from first tube to full-scale deployment, with practical tools, real-world lessons and decision frameworks in every chapter.

The Core Argument

The core argument on 42 CFR 493.1256, and why a lot transition and a new assay are different events.​

Regulatory and Standards Framework​

CLIA 493.1256, CLSI EP23, IQCP, EP19, and where the 20-day study comes from.​

Verification Requirements: New Control vs New Assay Implementation​

Requirements for each event side by side: control type, IQCP impact and documentation.​

The 1+4 Model​

One confirmatory run on Day 1, four monitoring runs on Days 2 to 5, and the documentation package.​

The Regulatory Argument​

What the regulation requires, the conditions for a single confirmatory run, and the case for doing more.​

New Assay and Platform Implementation​

Verification, IQCP and documentation for a new molecular assay or platform.​

Inspection Readiness and Accreditation​

How to document the phased approach and confirm your accreditor’s expectations.​

Decision Framework​

The verification approach by control type, IQCP status and institutional risk tolerance.​

Key Regulatory and Standards References​

CLIA, CLSI, CMS, CAP, COLA, Joint Commission and state sources behind lot verification.​

Take a look inside

Tables, decision frameworks and documentation lists you can bring into your next QC plan review.​

A decision framework​
The verification approach by control type and IQCP status.​

What you’ll be able to do

Know where the regulation stops. Document your reasoning. Verify at the depth your risk calls for.​

Right size the verification scope when switching controls vs new assay implementation.​

Match verification depth to your control type, IQCP status and institutional risk tolerance.​

Build transition record that documents a structured, risk-based process for inspection.​

Written for molecular and infectious disease laboratory teams

Whether your lab runs qualitative panels or quantitative viral load assays, the framework starts from the same questions: what is your control type, is your IQCP active, and what does your accreditation program expect?​

Laboratory technician loading samples into a benchtop instrument

Get the Laboratory Quality Control Verification Strategic Guidance​

10-page PDF. We’ll email you a copy.​